In some tumors, FFAR1 and FFAR4 have the opposite effect; for example, FFAR1 activation inhibits the motile activity of pancreatic cancer and osteosarcoma cells, while FFAR4 activation promotes these activities (31, 32). Here, FFAR1 is linked to familial pancreatic carcinoma.